Buy Etonitazepipne (opioid) Cas 734496-28-7
Etonitazepipne (N-piperidino etonitazene) is a benzimidazole derivative with opioid effects around 100 times more potent than morphine,[1][2] which has been sold over the internet as a designer drug.[3][4][5][6]
See also
References
- Hunger A, Kebrle J, Rossi A, Hoffmann K (1960). “Benzimidazol-Derivate und verwandte Heterocyclen III. Synthese von 1-Aminoalkyl-2-benzyl-nitro-benzimidazolen”. Helvetica Chimica Acta. 43 (4): 1032–1046. doi:10.1002/hlca.19600430412.
- Berardinelli D, Taoussi O, Carlier J, Tini A, Zaami S, Sundermann T, et al. (July 2024). “In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne)”. Clinical Chemistry and Laboratory Medicine. 62 (8): 1580–1590. doi:10.1515/cclm-2023-1360. PMID 38311816.
- “Alert from NDEWS Web Monitoring Team: Increase in discussion of etonitazepipne”. National Drug Early Warning System. Weekly Briefing (43). 9 July 2021.
- “Warnings Etonitazepipne”. Knowdrugs.app. 9 August 2021.
- Vandeputte MM, Verougstraete N, Walther D, Glatfelter GC, Malfliet J, Baumann MH, et al. (June 2022). “First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass”. Archives of Toxicology. 96 (6): 1865–1880. Bibcode:2022ArTox..96.1865V. doi:10.1007/s00204-022-03294-2. hdl:1854/LU-8751259. PMID 35449307. S2CID 253718213.
- Calello DP, Aldy K, Jefri M, Nguyen TT, Krotulski A, Logan B, et al. (September 2022). “Identification of a novel opioid, N-piperidinyl etonitazene (etonitazepipne), in patients with suspected opioid overdose”. Clinical Toxicology. 60 (9): 1067–1069. doi:10.1080/15563650.2022.2084406. PMC 9815205. PMID 35708103.
Reviews
There are no reviews yet.